Patents by Inventor Marc W. Andersen

Marc W. Andersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS OF CHOLINESTERASE INHIBITORS
    Publication number: 20100256229
    Abstract: The present invention is directed to compositions, methods of use, and processes for the synthesis related to 3-((S)-1-(dimethylamino)ethyl)phenyl methyl-((R)-1-phenylpropan-2 yl)carbamate, and its pharmaceutically acceptable salt forms, including the hydrogen fumarate salt. The present invention also relates to a novel form polymorph of 3-((S)-1-(dimethylamino)ethyl)phenylmethyl-((R)-1-phenylpropan-2 yl)carbamate, characterized by a unique X-ray diffraction pattern and Differential Scanning Calorimetry profile, as well a unique crystalline structure.
    Type: Application
    Filed: April 2, 2010
    Publication date: October 7, 2010
    Applicant: Colucid Pharmaceuticals, Inc.
    Inventors: Shoucheng Du, Marc W. Andersen, Daniel Coughlin, Alexander Kolchinski
  • Benzimidazole derivatives
    Patent number: 6455507
    Abstract: Benzimidazole derivatives useful for treating or preventing viral infections such as those caused by herpes viruses or in the treatment of restenosis following surgical techniques. Methods of preparing these benzimidazole derivatives and pharmaceutical compositions containing them are described.
    Type: Grant
    Filed: March 17, 2000
    Date of Patent: September 24, 2002
    Assignee: SmithKline Beecham Corporation
    Inventors: John Charles Drach, Leroy B. Townsend, Frank Leslie Boyd, Jr., Stanley Dawes Chamberlain, Susan Mary Daluge, David Norman Deaton, Marc W. Andersen, George Andrew Freeman
  • BENZIMIDAZOLE DERIVATIVES
    Publication number: 20020094963
    Abstract: The present invention relates to certain bezimidazole derivatives and their use in medical therapy particularly for the treatment or prophylaxis of virus infections such as those caused by herpes viruses. The invention also relates to the preparation of the benzimidazole derivatives and pharmaceutical formulations containing them.
    Type: Application
    Filed: March 17, 2000
    Publication date: July 18, 2002
    Inventors: JOHN CHARLES DRACH, LEROY B. TOWNSEND, FRANK LESLIE BOYD, STANLEY DAWES CHAMBERLAIN, SUSAN MARY DALUGE, DAVID NORMAN DEATON, MARC W. ANDERSEN, GEORGE ANDREW FREEMAN